Psoriatic arthritis: Is something changing?

Advances in Experimental Medicine and Biology

Volumn 455, Issue , 1999, Pages 207-214

  Scarpa, R ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; DICLOFENAC; GOLD SALT; INDOMETACIN; KETOPROFEN; MECLOFENAMIC ACID; METHOTREXATE; NAPROXEN; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; SALAZOSULFAPYRIDINE; TIAPROFENIC ACID;

ARTICULAR CARTILAGE; CLINICAL FEATURE; CONFERENCE PAPER; DISEASE CLASSIFICATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; PREVALENCE; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; SEROCONVERSION;

EID: 0033282384     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-4857-7_30     Document Type: Conference Paper

References (15)

1. Nomenclature and classification of arthritis and rheumatism (tentative) accepted by the American Rheumatism Association
2. Arthropathia Psoriasica-presentation of a case
3. Bone and joint changes associated with psoriasis
4. Psoriasis and arthritis
5. Familial occurrence of psoriatic arthritis
6. Natural history of psoriatic arthritis
7. Psoriatic arthritis in psoriatic patients
8. The clinical spectrum of psoriatic spondylitis
9. Psoriatic arthritis (PA): A clinical, immunological and radiological study of 180 patients
10. A re-evaluation of the osteoarticular manifestations of psoriasis
11. Iocco Met al. The management of 138 psoriatic arthritic patients
12. Serum type 111 procollagen aminopeptide for assessing liver damage in methotrexate-treated psoriatic patients
13. Long-term safety of cyclosporin in the treatment of psoriasis
14. Sulfasalazine in the treatment of spondy-loarthropathy: A randomized, multicenter, double-blind, placebo-controlled study